Scientists have developed a “highly sensitive” blood test that could detect signs of cancerous tumours years before the first symptoms appear, an advance that could lead to better treatment outcomes for patients.
Researchers from the Johns Hopkins University in the US found that genetic material shed by tumours can be detected in the bloodstream much before patients get their first diagnosis.
